Koninklijke DSM NV (DSM.AS) Forecast, Price Target & Analyst Ratings

AMS:DSM • NL0000009827

Current stock price

114.05 EUR
+0.15 (+0.13%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Koninklijke DSM NV (DSM.AS).

Forecast Snapshot

Consensus Price Target

Price Target
€151.14
+ 32.52% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2023
EPS Estimate
€0.47
Revenue Estimate
2.053B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
77.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€151.14
Upside
+ 32.52%
From current price of €114.05 to mean target of €151.14, Based on 24 analyst forecasts
Low
€101.00
Median
€153.00
High
€193.20

Price Target Revisions

1 Month
-0.38%
3 Months
-4.24%

Price Target Summary

24 Wall Street analysts provided a forecast for the next 12 months for DSM.AS. The average price target is 151.14 EUR. This implies a price increase of 32.52% is expected in the next year compared to the current price of 114.05.
The average price target has been revised downward by 4.24% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

DSM Current Analyst RatingDSM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

DSM Historical Analyst RatingsDSM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
77.50%
DSM.AS was analyzed by 24 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about DSM.AS.
In the previous month the buy percentage consensus was at a similar level.
DSM.AS was analyzed by 24 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2023
EPS Estimate
€0.47
Revenue Estimate
2.053B
Revenue Q2Q
-16.92%
EPS Q2Q
-63.05%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.20%
EPS (1 Month)
0.00%
EPS (3 Months)
-16.28%

Next Earnings Summary

The next earnings revenue estimate has been revised upward by 0.2% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
DSM.AS revenue by date.DSM.AS revenue by date.
8.106B
1.35%		7.269B
-10.33%		8.39B
15.42%		10.011B
19.32%		10.759B
7.47%		11.219B
4.28%		10.302B
-8.17%		10.871B
5.52%		11.467B
5.48%		12.091B
5.44%		12.749B
5.44%
EBITDA
YoY % growth
DSM.AS ebitda by date.DSM.AS ebitda by date.
1.468B
-0.14%		1.405B
-4.29%		1.315B
-6.41%		1.544B
17.41%		1.809B
17.16%		2.013B
11.28%		2.059B
2.29%		2.09B
1.51%		2.188B
4.69%		2.318B
5.94%		2.426B
4.66%
EBIT
YoY % growth
DSM.AS ebit by date.DSM.AS ebit by date.
728M
-13.13%		724M
-0.55%		663M
-8.43%		810.33M
22.22%		998.02M
23.16%		1.16B
16.23%		1.282B
10.52%		1.354B
5.62%		1.429B
5.54%		1.533B
7.28%		1.613B
5.22%
Operating Margin
DSM.AS operating margin by date.DSM.AS operating margin by date.
8.98%9.96%7.90%8.09%9.28%10.34%12.44%12.46%12.46%12.68%12.65%
EPS
YoY % growth
DSM.AS eps by date.DSM.AS eps by date.
4.29
-7.34%		N/A
20.70%		N/A
-19.13%		3.44
-17.84%		4.17
21.25%		4.77
14.35%		5.86
22.86%		6.25
6.56%		6.64
6.32%		7.21
8.54%		7.64
6.04%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24
EPS
Q2Q % growth		0.47
-63.05%		0.95
-4.49%		0.51
-49.11%		1.12
-12.37%		0.95
100.85%
Revenue
Q2Q % growth		2.053B
-16.92%		2.105B
-48.85%		2.23B
1.59%		2.171B
-49.22%		2.156B
5.02%
EBITDA
Q2Q % growth		283.05M
-39.49%		334.82M
-27.22%		383.8M
1.30%		367.14M
20.30%		N/A
EBIT
Q2Q % growth		135.57M
-53.43%		152.57M
-61.67%		93.739M
-63.65%		194.44M
-31.54%		222.42M
64.06%

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

DSM.AS Yearly Revenue VS EstimatesDSM.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
DSM.AS Yearly EPS VS EstimatesDSM.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
4.44%
EPS Next 5 Year
8.32%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
7.11%
Revenue Next 5 Year
3.55%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
31.75%
EBIT Next 5 Year
18.88%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Koninklijke DSM NV / DSM.AS Forecast FAQ

What is the average price target for Koninklijke DSM NV (DSM.AS) stock?

24 analysts have analysed DSM.AS and the average price target is 151.14 EUR. This implies a price increase of 32.52% is expected in the next year compared to the current price of 114.05.

What are the consensus estimates for Koninklijke DSM NV (DSM.AS) next earnings?

The consensus EPS estimate for the next earnings of Koninklijke DSM NV (DSM.AS) is 0.47 EUR and the consensus revenue estimate is 2.05B EUR.

How do analysts rate Koninklijke DSM NV (DSM.AS)?

The consensus rating for Koninklijke DSM NV (DSM.AS) is 77.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.